Therapeutic apheresis for severe hypertriglyceridemia in pregnancy
- 898 Downloads
During pregnancy, a progressive increase in serum triglyceride (TG) and cholesterol levels is observed whereas TG levels mostly remain <300 mg/dl. In women with genetic forms of hypertriglyceridemia, pregnancy may cause extremely elevated TG levels leading to potentially life-threatening pancreatitis attacks and chylomicronemia syndrome. The only safe medical treatment option during pregnancy is ω-3 fatty acids, which have moderate TG lowering effects. Therapeutic apheresis could be used as primary treatment approach during pregnancy.
Materials and methods
We reported the effect of double filtration apheresis in one pregnant women with severe hypertriglyceridemia, therapeutic plasmapheresis and double filtration methods in the other severe hypertriglyceridemic pregnant woman; a 32-year-old pregnant woman (patient 1) with a history of hypertriglyceridemia-induced acute pancreatitis during pregnancy and a 30-year-old pregnant woman with extremely high TG levels (12,000 mg/dl) leading to chylomicronemia syndrome (patient 2). Medical nutrition therapy and ω-3 fatty acids were also provided. Double filtration apheresis (patient 1) and plasmapheresis + double filtration apheresis (patient 2) were used.
Result and conclusion
When we calculated the TG levels before and after therapeutic apheresis, maximum decrease achieved with double filtration apheresis was 46.3 % for patient 1 and 37.3 % for patient 2. However, with plasmapheresis TG level declined by 72 % in patient 2. Plasmapheresis seemed to be more efficient to decrease TG levels. Iron deficiency anemia was the main complication apart from technical difficulties by lipemic obstruction of tubing system. Healthy babies were born. Delivery led to decreases in TG levels. It is concluded that during pregnancy therapeutic apheresis is an effective method to decrease extremely high TG levels and risks of its potentially life-threatening complications.
KeywordsHypertriglyceridemia Pregnancy Acute pancreatitis Plasmapheresis Double filtration apheresis
Conflict of interest
The authors certify that no actual or potential conflict of interest in relation to this article exists.
- 13.Szczepiorkowski ZM, Winters SL, Bandarenko N, Kim HC, Linenberger ML, Marques BM, Sarode R, Schwarts J, Weinstein R, Shaz BH (2010) Apheresis Application Committee of the American Society for Apheresis. Guidelines on the use of therapeutic apheresis in clinical practice. Evidence based approach from the Apheresis Applications Committee of American Society for Apheresis. J Clin Apher 25:83–177PubMedCrossRefGoogle Scholar
- 15.Safi F, Toumeh A, Abuissa Qadan MA, Karaz R, Alakdar B, Assaly R (2012). Management of familial hypertriglyceridemia-induced pancreatitis during pregnancy with therapeutic plasma exchange: a case report and review of literature. Am J Ther (Epub ahead of print)Google Scholar